Structural insights into the interaction of three Y-shaped ligands with PI3Kα

Area of Science:

• Biochemistry
• Structural Biology
• Medicinal Chemistry

Background:

• Class IA phosphoinositide 3-kinase alpha (PI3Kα) is frequently mutated in cancers, making it a key drug target.
• Existing PI3Kα inhibitors face safety issues due to poor selectivity.
• Novel chemical scaffolds and inhibition mechanisms are needed for effective PI3Kα-targeted therapies.

Purpose of the Study:

• To elucidate the structural basis of PI3Kα interaction with novel Y-shaped ligands.
• To explore a unique mechanism of kinase inhibition distinct from ATP-competitive binding.
• To provide insights for the rational design of next-generation PI3Kα inhibitors.

Main Methods:

• Cryo-electron microscopy (cryo-EM) was used to determine the structures of PI3Kα in complex with Y-shaped ligands.
• Structural analysis focused on ligand binding modes and their impact on PI3Kα conformation.
• Structure-activity relationship studies were performed to understand differential binding affinities.

Main Results:

• Three Y-shaped ligands (cpd16, cpd17, cpd18) were complexed with PI3Kα.
• Ligand cpd17 exhibited a unique binding mode, with arms occupying distinct pockets and inducing an unliganded-like PI3Kα conformation.
• Structural analysis revealed how stereochemical modifications influence ligand binding affinity.

Conclusions:

• The Y-shaped ligands bind PI3Kα via a non-ATP-competitive mechanism, inducing a unique conformational state.
• The distinct binding mode offers a potential strategy to overcome selectivity and safety issues of current inhibitors.
• These findings provide a foundation for developing novel therapeutic agents targeting PI3Kα in cancer.